Pharmaceutical Innovations and Advanced Scientific Research at UBT’s International Conference
27/10/2026As part of UBT’s International Conference, the International Conference on Pharmaceutical and Natural Sciences (IC-PNS 2026) brought together distinguished researchers and experts in the field at UBT’s campus.
During the conference, participants explored the latest developments in chemical research, advanced therapies, personalized medicine, and the impact of environmental and health-related factors on the natural sciences.
The following research papers were presented, addressing a wide range of topics in pharmaceutical and natural sciences:
- Bujar Qazimi – Chemical Profiling of Leaves and Flowers of Rosmarinus officinalis by LC-DAD-ESI-MS Method
- Elsa Hoti – Off-Label Drug Use: A Comparative Review of Regulatory Approaches
- Gentiana Balaj – Chemical Structure Profiles of Cardiovascular Drugs Used Among Hypertensive Patients
- Erza Berisha – UV-Vis Spectrophotometric Assessment of Metal-NSAID Interactions: A Study with Iron(III) and Copper(II)
- Leonida Gashi – Glycemic Control and Its Determinants Among Patients with Diabetes Mellitus in Kosovo: A Cross-Sectional Study
- Rina Hasani – Assessment of the Health Impacts of Environmental Pollution from KEK Activities on the Population of Obiliq Municipality
- Rina Nexhipi – Hematological and Metabolic Effects of Azithromycin Administration in Adult Mus musculus
- Gresa Halimi Syla – Bioisosteric Replacement and Its Applications in Drug Design and Development
- Rrona Mallaki – Effects of Curcumin in Doxorubicin-Treated Mus musculus Mice
- Dafina Krasniqi Hoxha – Herb-Drug Interactions in Primary Healthcare: Mechanisms, Clinical Significance, and the Pharmacist’s Role
- Reita Muharremi – Personalized Medicine: Future Perspectives in the Treatment of Rare Genetic Diseases
- Elsa Qenaj – Joubert Syndrome: A Rare Genetic Ciliopathy—Epidemiology, Molecular Pathogenesis, and Therapeutic Perspectives
- Olta Shehu – Mucopolysaccharidoses: Molecular Basis, Clinical Spectrum, and Therapeutic Perspectives with Focus on Type I and III
- Anjeza Temaj – Ribosome-Targeted Therapeutic Strategies for Severe Junctional Epidermolysis Bullosa and Other Genetic Diseases: From PTC Readthrough to Selective Ribosomal Editing
- Shkumbin Hamza – From Monogenic to Polygenic Obesity: Genomic Insights, Cardiometabolic Comorbidities, and the Role of Vitamin D in Pediatric Respiratory Health
- Yllka Gashi – Consanguinity, Rare Autosomal Recessive Disorders, and Ciliopathies in Southeast Europe: Genetic Architecture, Clinical Spectra, and Implications for Diagnosis and Counseling
- Mendor Xharra – Ribosome Dynamics, p53 Signaling, and Polyploid Giant Cancer Cells: Emerging Therapeutic Targets in Oncology and Genetic Disease
The conference provided a platform for scientific exchange and interdisciplinary dialogue, highlighting ongoing research and emerging approaches in pharmaceutical sciences, drug development, personalized medicine, genetics, and environmental health.
